Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trialRaches Ella, Siddhartha Dutta, DV Chalapathy et al.|The Lancet|2021Cited by 361
How old is streamwater? Open questions in catchment transit time conceptualization, modelling and analysisJeffrey J. McDonnell, S. Wrede, Jan Seibert et al.|Hydrological Processes|2010Cited by 355